XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Statement of Cash Flows [Abstract]    
Net income $ 1,180 $ 1,285
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for depreciation and net amortization 649 535
Provision for loan losses 160 360
Deferred net loan origination costs (95) (75)
Gain on sale of loans (349) (205)
Provision for (recapture of) servicing right valuation allowance 66 (141)
Loss on sale and write-down of foreclosed assets 189 200
Increase in cash surrender value of bank owned life insurance (101) (106)
Changes in operating assets and liabilities:    
Accrued interest receivable (111) (106)
Other assets 210 115
Other liabilities (1,445) (1,427)
Net cash provided by operating activities 353 435
Securities available for sale 5,526 4,631
Securities held to maturity 1,210 945
Securities available for sale (9,518) (12,428)
Securities held to maturity (1,537) (442)
Redemption of FHLB stock 383   
Net (increase) decrease in loans 951 (4,142)
Capital expenditures (99) (19)
Proceeds from sale of foreclosed assets    74
Purchase of bank-owned life insurance    (93)
Net cash used in investing activities (3,084) (11,474)
Net decrease in non-interest-bearing deposits (12,846) (6,870)
Net decrease in interest-bearing deposits (2,157) (14,104)
Net increase in FHLB advances    3,667
Net decrease in other borrowings (747) (4,057)
Dividends declared (3) (3)
Proceeds from exercise of stock options    4
Purchase of treasury stock (5)   
Net cash used in financing activities (15,758) (21,363)
Net decrease in cash and cash equivalents (18,489) (32,402)
Cash and cash equivalents at beginning 38,205 40,331
Cash and cash equivalents at end 19,716 7,929
Cash paid during the period for:    
Interest 1,924 2,353
Income taxes 310 475
Loans charged off 347 946
Loans transferred to foreclosed assets 358 135
Issuance of unvested restricted stock grants at fair value 200 200
Vesting of restricted stock grants $ 22 $ 26